From Clinical Milestones to Commercial Momentum: Building a Seamless Path to Launch
Keynote
Translating pivotal trial strategy into a differentiated launch narrative that resonates with regulators, payers, HCPs, and patients
Identifying critical inflection points during Phase II/III where commercial, medical, and access teams must engage early
Designing cross-functional governance models that prevent “handoff gaps” between clinical and commercial
Aligning endpoints, HEOR strategy, and real-world evidence plans to support pricing, reimbursement, and field readiness
Anticipating competitive and disease-state dynamics while still in development to shape pre-launch education strategies
Building internal launch readiness dashboards that integrate clinical progress with operational and commercial KPIs
Avoiding common pitfalls: late market shaping, misaligned messaging, and siloed decision-making
10:00 AM
Inside the Launch Decision Room: An Interview on the Choices That Make or Break a Product Launch and Readiness through an Organization
Go behind the scenes of real executive decision-making during the critical 12–24 months leading up to launch including team building and org structure, resource allocation, and external partners
Explore prioritize investments, manage risk, and balance speed vs. certainty across Medical, Commercial, and Market Access.
Learn how leadership teams align the entire organization around launch milestones, KPIs, and accountability.
Hear real examples of KOL/ HCP impact as well as successful partnerships with disease state associations
Understand how cross-functional collaboration and break down silos to accelerate readiness.
11:00 AM
Networking Break
11:30 AM
From Gap to Growth: Building Market Readiness Before Launch Through Disease Awareness, Partnerships, and Real-World Insight
Identifying healthcare system gaps, unmet needs, and disease recognition opportunities to shape the environment before product launch
Building early disease-state awareness campaigns and preparing the market through education, messaging, and competitive landscape analysis
Leveraging global and regional insights (including Japan and the U.S.) to tailor readiness strategies across healthcare systems, EMRs, and reimbursement environments
Partnering with professional societies, HCP congresses, advisory boards, and strategic collaborators to build credibility and engagement early
Understanding specialty vs. primary care dynamics and how they impact messaging, adoption, and market preparation
Using market research, patient advisory boards, and real-world evidence (RWE) to refine messaging, identify missing pieces, and demonstrate the “so what” impact
Activating partners and data sources (claims, RWE, and insights) to support early commercial, sales, and marketing readiness
12:00 PM
Embedding Launch Readiness into Early Development: Aligning Internal Strategy with External Medical and Market Communications
Building launch readiness into early development strategy, ensuring clinical, medical, and commercial teams align from Phase I/II through pre-launch planning
Defining the roles of Medical Affairs, Commercial, Market Access, and Regulatory in shaping early communication strategies and evidence generation
Developing disease state education and scientific communication strategies that prepare HCPs, patients, and advocacy groups ahead of launch
Understanding the balance between scientific exchange vs. promotional communication and how to engage external stakeholders compliantly pre-approval
Leveraging KOLs, advisory boards, and congress strategy to inform development decisions and shape the external scientific narrative
Coordinating internal launch readiness processes with external medical communications, including publications, congress presence, and education initiatives
Identifying early signals from the market, healthcare systems, and patient communities to refine launch strategy and ensure real-world adoption
1:00 PM
Lunch
2:00 PM
AI as the Launch Multiplier: Embedding Intelligence Into Clinical, Medical, and Commercial Workstreams
Identifying where AI creates real launch leverage: forecasting, segmentation, content review, competitive intelligence, and field optimization
Moving beyond pilots — building AI into SOPs, governance, and cross-functional workflows
Using predictive analytics to anticipate uptake curves, access barriers, and KOL engagement gaps
Leveraging AI to streamline MLR review and promotional material approval without increasing compliance risk
Connecting clinical data, real-world evidence, and market insights into unified dashboards for launch leaders
Aligning Commercial Operations, Marketing, and Medical Affairs around shared AI-driven KPIs
Avoiding common AI pitfalls: tool overload, siloed datasets, lack of adoption, and unclear ROI
2:45 PM
Building the AI-Enabled Launch Engine: Embedding Intelligent Workflows Across Marketing, Sales, and Commercial Operations
Learn how pre-commercial organizations can design scalable marketing and commercial systems while preparing for multiple launches, new indications, and reformulations.
Explore how to embed AI into core workflows across promotional review, content lifecycle management, speaker programs, and campaign execution to improve speed, quality, and compliance.
Understand how to connect marketing technologies, fulfillment systems, and CRM platforms to create a unified launch ecosystem and real-time performance visibility.
Discover how to develop meaningful marketing KPIs, dashboards, and insights that guide decision-making and support launch readiness.
Hear how cross-functional alignment across marketing, sales, IT, finance, and compliance enables governance, audit readiness, and scalable execution.
Walk away with practical strategies for making AI a core operating model—not a side project—to drive measurable commercial launch impact.
3:15 PM
Networking Break
3:45 PM
From Strategy to Uptake: Building a Commercial Launch Engine That Drives Awareness, Adoption, and Growth
Translate brand strategy into a launch-ready commercial plan that aligns marketing, sales, market access, and analytics around shared launch goals and timelines.
Build a scalable pre-launch awareness strategy that primes the market through segmentation, targeting, and omnichannel engagement.
Design the field readiness model—training, messaging, tools, and KPIs—to ensure confident and consistent execution from day one.
Leverage data, AI, and predictive analytics to identify priority audiences, personalize engagement, and optimize launch performance in real time.
Develop integrated campaigns that connect digital, in-person, and peer-to-peer channels to accelerate early adoption.
Align commercial messaging with Medical Affairs and Market Access to ensure consistent, compliant, and differentiated value communication.
Establish launch dashboards and performance metrics that track awareness, engagement, uptake, and long-term growth beyond the initial launch window
5:00 PM
End of Day One
Interested in learning more?
Click below to schedule a meeting with our sponsorship team!
Medical Affairs as the Strategic Launch Engine: Building the Team, Evidence, and Engagement Model for Launch Success
Keynote
Define how Medical Affairs leaders can shape launch strategy early by aligning evidence generation, insights, and cross-functional decision making across Commercial, Market Access, and Clinical teams.
Build and scale a high-impact Medical Affairs launch team—defining roles, capabilities, resourcing models, and training needed to support pre- and post-approval success.
Develop a modern KOL identification and engagement strategy that blends traditional thought leaders, rising experts, and digital opinion leaders to accelerate awareness and credibility.
Design a congress strategy that maximizes scientific presence, drives meaningful engagements, and translates congress insights into actionable launch plans.
Establish structured insight generation frameworks to capture field intelligence and turn it into strategic actions that influence launch readiness and lifecycle planning.
Create a compliant, scalable scientific engagement model that strengthens relationships with healthcare professionals before, during, and after launch.
Measure Medical Affairs launch impact using clear metrics and dashboards that demonstrate value to executive leadership and cross-functional partners.
11:00 AM
Networking Break
11:30 AM
Building the Launch Team: When to Hire, How to Scale, and Structuring Teams for Launch Success
Identifying the critical hiring milestones from late-stage clinical development through the first 12–24 months post-launch
Determining which roles to prioritize first across Medical Affairs, Commercial, Market Access, HEOR, and Launch Operations
Building a lean but scalable team structure that supports growth without over-hiring too early
Aligning leadership across Medical, Commercial, and Clinical teams to support evidence generation, KOL engagement, and launch readiness
Deciding when to build internally vs. leverage external partners, agencies, or consultants during early launch preparation
Structuring teams to support disease-state education, congress strategy, and early market shaping activities
Lessons learned from leaders who have built teams for first product launches and expanding portfolios
12:00 PM
Prepare for Market Access Success: Aligning HEOR, Pricing, and Value Strategy Before Launch
Identifying the critical inflection points during clinical development when HEOR and market access teams should begin shaping value strategy
Designing evidence generation plans that support payer expectations, reimbursement discussions, and long-term value demonstration
Building pricing strategies that balance innovation, access, and competitive market dynamics
Aligning Medical Affairs, HEOR, and Commercial teams to develop a clear value narrative for payers, providers, and health systems
Leveraging real-world evidence, outcomes research, and patient data to strengthen value dossiers and payer engagement
Preparing for payer advisory boards, early value discussions, and access negotiations prior to launch
Lessons learned from recent launches on avoiding access delays, pricing challenges, and reimbursement barriers
1:00 PM
Lunch
2:00 PM
Strategic Engagement Across the Ecosystem: Aligning KOLs, HCPs, and Patient Communities from Clinical Development to Launch
Identifying when to begin KOL engagement during early clinical development to shape trial design, endpoints, and disease-state awareness
Understanding the evolving role of HCP engagement from Phase II through post-launch, including advisory boards, congress strategy, and educational initiatives
Partnering with patient advocacy organizations and patient groups to better understand unmet needs, access challenges, and real-world treatment journeys
Clarifying which internal teams should lead engagement at each stage—Clinical, Medical Affairs, Market Access, and Commercial
Navigating the transition of stakeholder engagement from Medical Affairs–led scientific exchange to Commercial field engagement as launch approaches
Aligning MSLs, TLLs, and Commercial field teams to ensure consistent messaging, compliant communication, and strong stakeholder trust
Lessons from recent launches on building authentic relationships that drive adoption, education, and long-term market impact
2:45 PM
From Plan to Performance: Designing Launch Timelines, Communication Strategies, and Execution Frameworks
Building realistic launch timelines that connect clinical milestones, regulatory milestones, and commercial readiness
Aligning cross-functional teams across Medical Affairs, Commercial, Market Access, Regulatory, and Operations around a shared launch roadmap
Developing clear internal communication frameworks that keep leadership, field teams, and operational groups informed and aligned
Planning coordinated external communication strategies including congress announcements, press releases, disease awareness campaigns, and product messaging
Structuring launch readiness playbooks and dashboards to track progress across key functional areas
Preparing field teams and partners with the training, messaging, and tools needed for effective launch execution
Lessons learned from recent launches on avoiding timeline delays, misaligned messaging, and cross-functional breakdowns
3:30 PM
Launch Excellence: Metrics, KPIs, and Strategic Investments for the Next Generation of Drug Launches
Defining the next generation of launch KPIs beyond sales—including scientific engagement, access timelines, patient adoption, and real-world impact
Building launch dashboards that integrate medical, commercial, and access performance metrics for leadership visibility
Using data and predictive analytics to monitor launch progress and make real-time adjustments to strategy
Allocating budgets strategically across medical education, commercial engagement, digital channels, and patient support programs
Measuring the impact of KOL engagement, digital education, and field execution on launch adoption
Aligning cross-functional teams around shared success metrics to improve accountability and performance
Looking ahead to how AI, digital engagement, and new commercialization models will shape the future of launch strategy
- Align Teams for Impact Unite medical, commercial, access, and patient groups to drive confident launches. - Learn from Experts Hear real case studies and panels from leading pharma and biotech executives. - Harness AI & Data See how predictive insights and real‑world evidence transform launch success. - Stay Ahead of Competition Prepare for dozens of breakthrough therapies hitting the market in 2026. - Build Powerful Connections Network with senior leaders shaping launch excellence across the industry.
Yes! Bring your crew. Whether it’s your department, your leadership team, or your whole company — group registration is easy and comes with perks. Discounts? You bet. Better collaboration back at the office? Definitely. Reach out to us for custom group packages and let’s make it a team experience.
The Launch Readiness Summit is the only cross-functional gathering designed to bring together Medical Affairs, Commercial/Marketing, Market Access, HEOR, Field Teams, Patient Engagement, and Data/Analytics to build a unified, de-risked, and impact-driven launch plan.
We make networking feel natural — not awkward. From structured roundtables and topic lounges to networking receptions and interactive sessions, there are plenty of ways to meet people who matter to your work (and might just become collaborators or friends). Just bring your curiosity — we’ll handle the rest.
-Learn and implement different metrics for measuring the success of your KOL interactions and to benchmark against other TLLs
-Craft effective TLL Business Planning and Development that secures cross-functional effective collaboration for the overall success of the company
-Explore different tools and ways to work with your KOLs and DOLs, learn best practices on how the industry is managing its interactions
-Find innovative ways to keep HCPs engaged and interested in your speaker programs
-Understand the compliance and ethics considerations for TLLs on their internal and external interactions and engagement to guarantee successful engagement
The ONLY Thought Leader Liaison-focused event in the Pharma industry is COMING BACK for its 5th Edition!
The 5th Thought Leader Liaison Engagement Summit is the only conference that focuses entirely on the TLL/Regional Marketing role within the Pharmaceutical industry. Emphasizing on TLL strategies, using of technology and enhancing HCP engagement across the board, in advisory boards, speaker programs in a compliant manner and the KOL-DOL strategizing and prioritizing, learning from established TLL teams and their successful implementation of new tactics.
The Notary Hotel, Philadelphia, Autograph Collection 21 North Juniper Street, Philadelphia, PA, 19107, US
A limited and exclusive room block is available for our 5th Thought Leader Liaison Engagement Summit. To take advantage of our discounted room rate please click here.
Please note there is only one official, exclusive housing block for this event. Any other channels for booking reservations are not authorized. If you are contacted by a 3rd party housing company claiming to have a relationship with Momentum Events Group LLC, its event and/or Wyndham Lake Buena Vista; these companies and others like it are not in any way affiliated with us.
Sponsorship is a great way to enhance your brand’s visibility and help you connect with top-level decision-makers, innovators, and industry disruptors. There are a number of ways to maximize branding opportunities at the summit.
Interested in learning more about Sponsorship Opportunities?
.png?width=1900&height=550&name=310W25-HERO-EMAIL-FINAL%20(1).png)
